These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7875642)

  • 21. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
    Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
    J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of nefazodone and its metabolites in plasma by high-performance liquid chromatography with coulometric detection.
    Franklin M
    J Pharm Biomed Anal; 1993; 11(11-12):1109-13. PubMed ID: 8123721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of pharmacokinetic and pharmacodynamic drug interactions between nefazodone and digoxin in healthy male volunteers.
    Dockens RC; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 1996 Feb; 36(2):160-7. PubMed ID: 8852392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.
    Marino MR; Langenbacher KM; Hammett JL; Nichola P; Uderman HD
    J Clin Psychopharmacol; 1997 Feb; 17(1):27-33. PubMed ID: 9004054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.
    Marathe PH; Salazar DE; Greene DS; Brennan J; Shukla UA; Barbhaiya RH
    Pharm Res; 1995 Nov; 12(11):1716-21. PubMed ID: 8592675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the metabolites of the antidepressant drug nefazodone in human urine and plasma.
    Mayol RF; Cole CA; Luke GM; Colson KL; Kerns EH
    Drug Metab Dispos; 1994; 22(2):304-11. PubMed ID: 8013286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbamazepine-nefazodone interaction in healthy subjects.
    Laroudie C; Salazar DE; Cosson JP; Cheuvart B; Istin B; Girault J; Ingrand I; Decourt JP
    J Clin Psychopharmacol; 2000 Feb; 20(1):46-53. PubMed ID: 10653208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic evaluation during coadministration of nefazodone and propranolol in healthy men.
    Salazar DE; Marathe PH; Fulmor IE; Lee JS; Raymond RH; Uderman HD
    J Clin Pharmacol; 1995 Nov; 35(11):1109-18. PubMed ID: 8626885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.
    Dockens RC; Rapoport D; Roberts D; Greene DS; Barbhaiya RH
    Br J Clin Pharmacol; 1995 Dec; 40(6):598-601. PubMed ID: 8703669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets.
    Abdallah H; Jerling M
    J Clin Pharmacol; 2005 Jul; 45(7):802-9. PubMed ID: 15951470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open-label, single-dose, parallel-group study of the effects of chronic hepatic impairment on the safety and pharmacokinetics of desvenlafaxine.
    Baird-Bellaire S; Behrle JA; Parker VD; Patat A; Paul J; Nichols AI
    Clin Ther; 2013 Jun; 35(6):782-94. PubMed ID: 23623756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of the prolactin-stimulating and hyperthermic effects of nefazodone after subacute treatment.
    Walsh AE; Cowen PJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):268-73. PubMed ID: 7962683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.
    Shukla UA; Marathe PH; Pittman KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):502-7. PubMed ID: 8100508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.
    Barbhaiya RH; Dandekar KA; Greene DS
    Drug Metab Dispos; 1996 Jan; 24(1):91-5. PubMed ID: 8825195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nefazodone poisoning: toxicokinetics and toxicodynamics using continuous data collection.
    Isbister GK; Hackett LP
    J Toxicol Clin Toxicol; 2003; 41(2):167-73. PubMed ID: 12733855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
    Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteers.
    Robbins DK; Hutcheson SJ; Miller TD; Green VI; Bhargava VO; Weir SJ
    Biopharm Drug Dispos; 1997 May; 18(4):325-34. PubMed ID: 9158880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.
    van Laar MW; van Willigenburg AP; Volkerts ER
    J Clin Psychopharmacol; 1995 Feb; 15(1):30-40. PubMed ID: 7714226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.